{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:24:57Z","timestamp":1793121897942,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.spen.2021.100879","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T10:38:57Z","timestamp":1613385537000},"page":"100879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Niemann-Pick Disease, Type C: Diagnosis, Management and Disease-Targeted Therapies in Development"],"prefix":"10.1016","volume":"37","author":[{"given":"Elizabeth","family":"Berry-Kravis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2021.100879_bib0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2021.100879_bib0002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/humu.20636","article-title":"NPC-db, a Niemann-Pick type C disease gene variation database","volume":"29","author":"Runz","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2021.100879_bib0003","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1022575511354","article-title":"Lipid changes in Niemann-Pick disease type C brain: Personal experience and review of the literature","volume":"24","author":"Vanier","year":"1999","journal-title":"Neurochem Res"},{"key":"10.1016\/j.spen.2021.100879_bib0004","first-page":"178","article-title":"Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen","volume":"750","author":"Vanier","year":"1983"},{"key":"10.1016\/j.spen.2021.100879_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/gim.2015.25","article-title":"High incidence of unrecognized visceral\/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets","volume":"18","author":"Wassif","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.spen.2021.100879_bib0006","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ymgme.2016.12.003","article-title":"Differences in Niemann- Pick disease Type C symptomatology observed in patients of different ages","volume":"120","author":"Mengel","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2021.100879_bib0007","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3109\/00207454.2016.1161623","article-title":"Niemann-Pick type C: Focus on the adolescent\/adult onset form","volume":"126","author":"Di Lazzaro","year":"2016","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.spen.2021.100879_bib0008","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"International Niemann-Pick Disease Registry (INPDR). Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2021.100879_bib0009","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/302626","article-title":"Niemann-Pick C1 disease: The I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype","volume":"65","author":"Millat","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2021.100879_bib0010","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1074\/jbc.M708735200","article-title":"Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding","volume":"283","author":"Gelsthorpe","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.spen.2021.100879_bib0011","first-page":"24","article-title":"Niemann-Pick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterations","volume":"109","author":"Ribeiro","year":"2001"},{"key":"10.1016\/j.spen.2021.100879_bib0012","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/320606","article-title":"Niemann-Pick C1 disease: Correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop","volume":"68","author":"Millat","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2021.100879_bib0013","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10255","article-title":"Identification of 58 novel mutations in Niemann-Pick disease type C: Correlation with biochemical phenotype and importance of PTC1-like domains in NPC1","volume":"22","author":"Park","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2021.100879_bib0014","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ymgme.2005.07.007","article-title":"Niemann-Pick C disease: Use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families","volume":"86","author":"Millat","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2021.100879_bib0015","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1086\/324068","article-title":"Niemann-Pick disease type C: Spectrum of HE1 mutations and genotype\/phenotype correlations in the NPC2 group","volume":"69","author":"Millat","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2021.100879_bib0016","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2326","article-title":"Development of a bile acid based newborn screen for Niemann-Pick disease type C","volume":"8","author":"Jiang","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.spen.2021.100879_bib0017","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/1756285616635964","article-title":"Diagnostic workup and management of patients with suspected Niemann Pick type C disease","volume":"9","author":"Papandreou","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.spen.2021.100879_bib0018","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajmg.a.32642","article-title":"The clinical spectrum of fetal Niemann-Pick type C","volume":"149A","author":"Spiegel","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.spen.2021.100879_bib0019","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2009.06.008","article-title":"Recommendations on the diagnosis and management of Niemann-Pick disease type C","volume":"98","author":"Wraith","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2021.100879_bib0020","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1212\/WNL.0b013e31828869f9","article-title":"Niemann Pick type C is frequent in adult ataxia with cognitive decline and vertical gaze palsy","volume":"80","author":"Schicks","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2021.100879_bib0021","article-title":"Niemann-Pick disease type C2 presenting as fatal pulmonary alveolar lipoproteinosis: Morphological findings in lung and nervous tissue","volume":"14","author":"Bjurulf","year":"2008","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.spen.2021.100879_bib0022","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/DBP.0000000000000785","article-title":"Neurodevelopmental characterization of young children diagnosed with Niemann-Pick Disease, Type C1","volume":"41","author":"Thurm","year":"2020","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.spen.2021.100879_bib0023","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/dmcn.12970","article-title":"Cohort study of neurocognitive functioning and adaptive behaviour in children and adolescents with Niemann- Pick Disease type C1","volume":"58","author":"Thurm","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2021.100879_bib0024","article-title":"Protriptyline and severe cataplexy in Niemann-Pick type C1","volume":"80","author":"Berry-Kravis","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2021.100879_bib0025","first-page":"624","article-title":"Metastatic hepatocellular carcinoma in a patient with Niemann-Pick disease, type C","volume":"37","author":"Birch","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.spen.2021.100879_bib0026","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: A randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2021.100879_bib0027","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0883073809344222","article-title":"Long-term miglustat therapy in children with Niemann-Pick disease type C","volume":"25","author":"Patterson","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2021.100879_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-015-0284-z","article-title":"Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: An observational cohort study","volume":"10","author":"Patterson","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2021.100879_bib0029","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13023-020-01363-2","article-title":"Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: A final report of the NPC Registry","volume":"15","author":"Patterson","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2021.100879_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12245","article-title":"Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: a large retrospective observational study","author":"Patterson","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2021.100879_bib0031","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9823","article-title":"Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses","volume":"8","author":"Kirkegaard","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.spen.2021.100879_bib0032","unstructured":"https:\/\/www.orphazyme.com\/news-feed\/2019\/1\/30\/orphazyme-reports-positive-results-from-full- dataset-of-phase-iiiii-arimoclomol-trial-in-niemann-pick-disease-type-c-npc"},{"key":"10.1016\/j.spen.2021.100879_bib0033","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","article-title":"Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C","volume":"153","author":"Yanjanin","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.spen.2021.100879_bib0034","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0880-9","article-title":"Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials","volume":"13","author":"Cortina-Borja","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2021.100879_bib0035","unstructured":"https:\/\/www.orphazyme.com\/news-feed\/2020\/1\/3\/orphazyme-reports-positive-arimoclomol-datafrom-open-label-phase-23-extension-in-niemann-pick-disease-type-c"},{"key":"10.1016\/j.spen.2021.100879_bib0036","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.spen.2021.100879_bib0037","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.spen.2021.100879_bib0038","doi-asserted-by":"crossref","first-page":"e6951","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.spen.2021.100879_bib0039","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.spen.2021.100879_bib0040","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick Disease, type C1: An ad-hoc analysis of a non-randomized, open-label, phase 1\/2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2021.100879_bib0041","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2017.12.014","article-title":"Long-term treatment of Niemann-Pick Type C1 disease with intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin","volume":"80","author":"Berry-Kravis","year":"2018","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100879_bib0042","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13023-018-0913-4","article-title":"Adult NiemannPick disease type C in France: Clinical phenotypes and long-term miglustat treatment effect","volume":"13","author":"Nadjar","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2021.100879_bib0043","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13023-019-0996-6","article-title":"Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: An international, multicenter, retrospective chart review","volume":"14","author":"Pineda","year":"2019","journal-title":"Orphanet J Rare Dis"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909121000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909121000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:38:03Z","timestamp":1761028683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909121000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":43,"alternative-id":["S1071909121000073"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2021.100879","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niemann-Pick Disease, Type C: Diagnosis, Management and Disease-Targeted Therapies in Development","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2021.100879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100879"}}